PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
18-Dec-2019 MR Solutions participates in the first nanomedicine joint annual meeting in Dijon MR Solutions
18-Dec-2019 Domain Therapeutics and Pr Michel Bouvier (IRIC Montreal) receive the RSRI award for bioSens-All™ project at ADRIQ-RCTi Innovation Prize gala Domain Therapeutics
18-Dec-2019 Sanofi Wins Prestigious Drug Discovery Award for Innovative Rare Blood Clotting Disorder Treatment[1] Sanofi
18-Dec-2019 Newcells Biotech Win Phase II of CRACK IT Challenge 29: ImmuLiver Newcells Biotech
18-Dec-2019 World first treatment with ‘acoustic cluster therapy’ to improve chemotherapy delivery The Institute of Cancer Research
18-Dec-2019 Vaccitech Oncology Limited enters collaboration with Cancer Research UK to fund a Phase I/IIa clinical trial as first-line NSCLC therapy Vaccitech Ltd
17-Dec-2019 Novartis receives positive CHMP opinion for Beovu® (brolucizumab) for the treatment of wet AMD Novartis UK
17-Dec-2019 NICE recommends Vifor Pharma’s Veltassa® (patiromer) for adults with hyperkalaemia in England[i] Vifor Pharma UK
17-Dec-2019 From cancer medication to antibiotic: modified cancer drug effective against multi-resistant bacteria TECHNICAL UNIVERSITY OF MUNICH
16-Dec-2019 CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma Genmab A/S
16-Dec-2019 Helsinn to present a scientific poster on acute care use following CINV prophylaxis with agents in breast cancer patients at the San Antonio Breast Cancer Symposium (SABCS) 2019 Helsinn
16-Dec-2019 Novartis receives positive CHMP opinion for Beovu® (brolucizumab) for the treatment of wet AMD Novartis
16-Dec-2019 GAEU´s clients winners at the premiere of the EIC Accelerator GAEU Consulting AB
16-Dec-2019 V-Bio Ventures invests in Augustine Therapeutics, a VIB and KU Leuven spin-off to fight neuromuscular diseases V-Bio Ventures
16-Dec-2019 Research Article Cites HemoVoid™ in Biomarker Study for Parkinson’s Disease Biotech Support Group LLC
16-Dec-2019 Pfizer Receives Positive CHMP Opinion for VYNDAQEL® (tafamidis) for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease Pfizer Ltd
13-Dec-2019 CGT Catapult hosts second annual workshop to address digital challenges in adoption of advanced therapies by the NHS Advanced Therapy Medicinal Products (ATMPs) are
13-Dec-2019 UKI2S, CATAPULT VENTURES AND JONATHAN MILNER INVEST £500K IN GENE MODULATION NEWCOMER PENCIL BIOSCIENCES : UK Innovation & Science Seed Fund
13-Dec-2019 OXGENE™ announces year of continued growth and first licensing deals in Asia OXGENE™
13-Dec-2019 All haemophilia A patients in Republic of Ireland get continued access to Sobi’s extended half-life factor replacement therapy Sobi